What is one of the primary goals of ECMO therapy?

What is one of the primary goals of ECMO therapy?

• A. Avoid the use of anticoagulants
• B. Provide organ support while allowing recovery
• C. Increase the metabolic demand of patients
• D. Shift patient care to outpatient settings

Answer: (B)

One of the primary goals of ECMO therapy is to provide organ support while allowing recovery. ECMO is a life-sustaining treatment designed to temporarily replace the function of the heart and lungs in critically ill patients. This allows time for the underlying condition, such as severe respiratory failure or cardiac failure, to resolve or improve. The primary aim is to oxygenate the blood and remove carbon dioxide while supporting organ function, thereby allowing the patient's own heart and lungs the opportunity to heal. While the use of anticoagulants is an important consideration in ECMO management, the primary aim is not to avoid their use but rather to maintain appropriate anticoagulation to prevent thrombosis within the ECMO circuit. The metabolic demand of patients is not increased; rather, ECMO is used to stabilize patients who are unable to meet their metabolic needs on their own. Additionally, ECMO is typically provided in an inpatient setting, particularly in intensive care, rather than shifting to outpatient care, which would not be appropriate given the level of monitoring and support that these patients require.

One of the primary goals of ECMO therapy is to provide organ support while allowing recovery. ECMO is a life-sustaining treatment designed to temporarily replace the function of the heart and lungs in critically ill patients. This allows time for the underlying condition, such as severe respiratory failure or cardiac failure, to resolve or improve. The primary aim is to oxygenate the blood and remove carbon dioxide while supporting organ function, thereby allowing the patient's own heart and lungs the opportunity to heal.

While the use of anticoagulants is an important consideration in ECMO management, the primary aim is not to avoid their use but rather to maintain appropriate anticoagulation to prevent thrombosis within the ECMO circuit. The metabolic demand of patients is not increased; rather, ECMO is used to stabilize patients who are unable to meet their metabolic needs on their own. Additionally, ECMO is typically provided in an inpatient setting, particularly in intensive care, rather than shifting to outpatient care, which would not be appropriate given the level of monitoring and support that these patients require.